PARP-8 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of poly(ADP-ribose) polymerase 8 (PARP-8), a member of the PARP family of enzymes. PARP-8 is involved in various cellular processes, particularly those related to DNA repair, chromatin structure regulation, and post-translational modifications. Like other PARP enzymes, PARP-8 catalyzes the addition of ADP-ribose units to target proteins, a process known as ADP-ribosylation. This modification influences a variety of cellular functions, including protein-protein interactions, signaling pathways, and the maintenance of genome integrity. By inhibiting PARP-8, these compounds interfere with its ability to regulate ADP-ribosylation, thereby impacting key molecular processes within the cell.
The mechanism of PARP-8 inhibitors involves binding to the catalytic domain of the enzyme, blocking its ability to transfer ADP-ribose units to substrates. This inhibition affects various biological functions, particularly those involved in cellular stress responses and DNA damage signaling. Researchers use PARP-8 inhibitors to investigate the specific roles of PARP-8 in cellular processes, distinguishing its function from other members of the PARP family. This provides a better understanding of how PARP-8 regulates post-translational modifications and contributes to overall cellular homeostasis. The inhibition of PARP-8 also allows for a deeper exploration of the enzyme's role in regulating chromatin structure, gene expression, and cellular responses to environmental stress. These inhibitors offer important tools for dissecting the molecular functions of PARP-8 and its influence on cell biology, providing valuable insights into how ADP-ribosylation controls various aspects of cellular behavior.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
A known inhibitor of PARP1 and PARP2; it's uncertain but possible it could affect PARP-8. | ||||||
Rucaparib | 283173-50-2 | sc-507419 | 5 mg | $150.00 | ||
Another inhibitor for PARP1 and PARP2; might influence PARP-8 activity. | ||||||
Talazoparib | 1207456-01-6 | sc-507440 | 10 mg | $795.00 | ||
Inhibits PARP enzymes; potential for PARP-8 inhibition. | ||||||
Niraparib | 1038915-60-4 | sc-507492 | 10 mg | $150.00 | ||
Targets several PARP enzymes; its effect on PARP-8 is uncertain. | ||||||
Veliparib | 912444-00-9 | sc-394457A sc-394457 sc-394457B | 5 mg 10 mg 50 mg | $178.00 $270.00 $712.00 | 3 | |
Another PARP1/2 inhibitor; potential influence on PARP-8 is not clear. | ||||||
3-Aminobenzamide | 3544-24-9 | sc-3501 sc-3501B sc-3501A | 100 mg 1 g 5 g | $15.00 $36.00 $51.00 | 18 | |
A classic PARP inhibitor; its specificity across the PARP family is not well detailed. | ||||||
PARP Inhibitor VIII, PJ34 | 344458-15-7 | sc-204161 sc-204161A | 1 mg 5 mg | $57.00 $139.00 | 20 | |
Broad-spectrum PARP inhibitor; exact influence on PARP-8 is uncertain. | ||||||
AG 14699 | 459868-92-9 | sc-480370 | 25 mg | $13400.00 | ||
PARP1/2 inhibitor; potential for PARP-8 influence is uncertain. | ||||||
UPF 1069 | 1048371-03-4 | sc-361396 sc-361396A | 5 mg 25 mg | $89.00 $351.00 | 1 | |
A PARP2 inhibitor; its effect on PARP-8 is uncertain. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
Though primarily a tankyrase inhibitor, it affects the PARP family; influence on PARP-8 remains uncertain. | ||||||